carbamazepine has been researched along with Blepharospasm in 4 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Blepharospasm: Excessive winking; tonic or clonic spasm of the orbicularis oculi muscle.
Excerpt | Relevance | Reference |
---|---|---|
"To observe the efficacy of the combined treatment of carbamazepine and botulinum toxin A for blepharospasm and hemifacial spasm." | 9.16 | Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm. ( Hong, YC; Hu, YF; Li, XH; Lin, SC; Liu, JB; Liu, LY, 2012) |
"Carbamazepine was used as an anti-myotonic agent in three cases with the Schwartz-Jampel syndrome." | 5.29 | Improvement of myotonia with carbamazepine in three cases with the Schwartz-Jampel syndrome. ( Gücüyener, K; Okan, M; Serdaroğlu, A; Topaloğlu, H; Topçu, M, 1993) |
"To observe the efficacy of the combined treatment of carbamazepine and botulinum toxin A for blepharospasm and hemifacial spasm." | 5.16 | Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm. ( Hong, YC; Hu, YF; Li, XH; Lin, SC; Liu, JB; Liu, LY, 2012) |
"In cases of hemifacial spasm, inadequate results of botulinum toxin injections are even more unusual." | 1.34 | [What to do in cases of inadequate effectiveness of botulinum toxin for the treatment of eyelid cramping?]. ( Roggenkämper, P, 2007) |
"Carbamazepine was used as an anti-myotonic agent in three cases with the Schwartz-Jampel syndrome." | 1.29 | Improvement of myotonia with carbamazepine in three cases with the Schwartz-Jampel syndrome. ( Gücüyener, K; Okan, M; Serdaroğlu, A; Topaloğlu, H; Topçu, M, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Takeno, A | 1 |
Kanazawa, I | 1 |
Morita, M | 1 |
Takedani, K | 1 |
Miyake, H | 1 |
Yamamoto, M | 1 |
Nogami, K | 1 |
Kaneko, S | 1 |
Sugimoto, T | 1 |
Li, XH | 1 |
Lin, SC | 1 |
Hu, YF | 1 |
Liu, LY | 1 |
Liu, JB | 1 |
Hong, YC | 1 |
Roggenkämper, P | 1 |
Topaloğlu, H | 1 |
Serdaroğlu, A | 1 |
Okan, M | 1 |
Gücüyener, K | 1 |
Topçu, M | 1 |
1 trial available for carbamazepine and Blepharospasm
Article | Year |
---|---|
Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm.
Topics: Adult; Aged; Anticonvulsants; Blepharospasm; Botulinum Toxins, Type A; Carbamazepine; Drug Administr | 2012 |
3 other studies available for carbamazepine and Blepharospasm
Article | Year |
---|---|
A case report of fulminant type 1 diabetes mellitus associated with drug-induced hypersensitivity syndrome in an elderly patient with coxsackie B4 virus infection and human leukocyte antigen-A24 haplotype.
Topics: Aged; Anti-Inflammatory Agents; Anticonvulsants; Blepharospasm; Carbamazepine; Combined Modality The | 2018 |
[What to do in cases of inadequate effectiveness of botulinum toxin for the treatment of eyelid cramping?].
Topics: Administration, Oral; Anticonvulsants; Antipsychotic Agents; Blepharospasm; Botulinum Toxins, Type A | 2007 |
Improvement of myotonia with carbamazepine in three cases with the Schwartz-Jampel syndrome.
Topics: Blepharospasm; Carbamazepine; Child; Child, Preschool; Female; Humans; Locomotion; Male; Myotonia; N | 1993 |